Mayuka Labs Pvt Ltd Hyderabad

Country/Region: India     State/Province: New Delhi

Main Products: Rivaroxaban, Rivaroxaban

Company Introduction
Our Rivaroxaban goes through a top-notch quality analysis system supervised by skilled quality auditors who assess different products at different level. We have developed a state-of-the-art facility located in NEW DELHI, , India, laced with all the required amenities to keep the Rivaroxaban quality consistent and maintained. Buyers can reach us for acquiring first in class Rivaroxaban, as we are enlisted among best in class Manufacturers since 2014.Entire product line from Mayuka Labs Pvt Ltd Hyderabad Private Owner are made available in different variations with quality commitments that has no match, making our Rivaroxaban and Rivaroxaban highly demanded in the international market. Owing to which our export ratio value has reached US$1 Million - US$2.5 Million based on Australia,Canada,India,South Korea,Saudi Arabia market share. Being a quality-conscious entity and a leading Supplier of Rivaroxaban, we make sure that all our products perfectly comply with the laid industry standards and boast supreme quality. This approach throughout our 6 Years of export history led us to acquire Approx 5 Million US Dollar of yearly output.Our professional enterprise was first launched with Below US$1 Million of initial investment under Own Lisence.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2014, 2014

Legal Status: Own Lisence

Ownership: Private Owner

Employees: 101 - 200 People

Factory Size: 3, 000-5, 000 square meters

R&D Team Size: 11 - 50 People

Certifications: BRC

Contact Information

Contact Person: santosh

Designation: Marketing Manager

Department: M/D

Telephone: 91918801000000

Business Information

Main Markets: Australia (29%) India (28%) Saudi Arabia (23%) South Korea (20%) Canada (18%)

Export Focus: Australia, Canada, India, South Korea, Saudi Arabia

Contract Services: OEM Service Offered

Trade & Financial Information

Annual Revenue: Approx 5 Million US Dollar

Registered Capital: Below US$1 Million

Export Percentage: 91% - 100%

Payment Terms: Bank wire (T/T)

Product Showcase
Rivaroxaban
Rivaroxaban

CL-Link > Health & Medicines in India Health & Medicines in New Delhi Medicines in India Medicines in New Delhi Rivaroxaban in India Rivaroxaban in New Delhi